×

Head and Neck Surgical/Cytopathology




Evaluated by: David B. Kaminsky, M.D., FIAC on September 24, 2017
Access to this course expires on: June 3, 2020.
Course Director: Paul E. Wakely Jr., M.D
CME / SAMs 11.75

Course Description
This interactive microscopy course is designed to address the professional practice gap and knowledge needs in the analysis of specimens from the head and neck region that encompasses a diversity of tissue types leading to a broad array of pathologic alterations manifest as cellular and tissue aberrations. Pathologists continue to experience difficulty in diagnostic criteria for papillary and follicular thyroid lesions, particularly with changing terminology for papillary lesions, bewildering metaplastic changes in salivary glands, appropriate application of HPV testing and algorithms to determine tumors of unknown origin metastatic to head and neck. This panorama of experts will delve into these issues and update learners in a mentoring relationship at multihead microscopes, simulating clinical signout, and providing real-time interaction. The union of microscopy with adjunctive molecular and genetic tests creates a unique learning experience in a resort destination.

Targe Audience
Practicing academic and community pathologists, and pathologists-in-training

Learning Objectives 
Upon completion of this educational activity, learners will be able to:
  • Recognize the correlative features between cytopathology & histopathology of head/neck lesions
  • Describe morphologic features of newly described entities
  • Examine key diagnostic and clinical clues across a spectrum of head/neck lesions
  • Highlight diagnostic pitfalls for tissue sections and cytologic smears in a variety of thyroid, salivary gland lesions
  • Advise practical application of immunohistochemical markers and molecular assays

The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 11.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

The USCAP is approved by the American Board of Pathology (ABP) to offer Self-Assessment credits (SAMs) for the purpose of meeting the ABP requirements for Maintenance of Certification (MOC). Registrants must take and pass the post-test in order to claim SAMs credit.

Physicians can earn a maximum of 11.75 SAM credit hours.

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty reported no relevant financial relationships: Paul E. Wakely, Jr., M.D., Syed Z. Ali, M.D., FRCPath, FIAC, Raja R. Seethala, M.D., Bruce M. Wenig, M.D. 

USCAP staff associated with the development of content for this activity reported no relevant financial relationships.

To earn CME and SAM credit, all learners must take a content-based exam and achieve a minimum score of 80%. If learners do not achieve a passing score of 80%, they have the option to retake the exam. After you pass the test and complete the evaluation, your certificate of completion will be available to view and print by clicking here.